Advancing Cancer Research: How E-BLOT Enabled Precision Imaging in a Landmark Hepatocellular Carcinoma Study
The Study: A New Chapter in Immune Evasion
Title: A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma
Journal: Cell Research (Nature Publishing Group)
Access: Open Access — Read Here
In A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma (Jiang et al., 2023), researchers discovered that MLKL, best known as a necroptosis executioner, also prevents metabolic-stress-induced parthanatos in liver tumors—helping cancer cells evade immune destruction.
To prove this, they visualized:
Cleaved PARP1
AIF nuclear translocation
MLKL expression across knockouts, knockdowns, and reconstituted lines
Western blotting was central to every molecular conclusion—and the Pro E-BLOT Touch Imager powered it.
Where E-BLOT Shined: Key Figures and What They Show
| Figure 3f: MLKL deficiency enhances metabolic stress-induced parthanatos. (Reproduced with permission from Jiang et al., Cell Research, 2023.) | Target: Poly(ADP-ribose) (PAR), a hallmark of parthanatos Context: Shows enhanced PAR accumulation in MLKL-KO cells upon palmitic acid (PA) treatment E-BLOT Output: Sharp bands, minimal background, quantifiable densitometry-ready signal |
| Supplementary Fig. S3 MLKL deficiency enhances metabolic stress-induced parthanatos. (Reproduced with permission from Jiang et al., Cell Research, 2023.)
|
Target: MLKL, PAR, GAPDH Insight: Time and dose-dependent accumulation of PAR polymer; supports activation of parthanatos E-BLOT Value: Consistent exposure across blots; side-by-side comparability across conditions |
|
Supplementary Fig. S5 MLKL deficiency disrupts Mg2+ homeostasis in the ER. (Reproduced with permission from Jiang et al., Cell Research, 2023.)
|
Target: MLKL, Calnexin, VDAC, H2A Use Case: Confirms subcellular localization of MLKL in ER fraction E-BLOT Strength: Highly specific banding across cellular compartments; supports ER-Mg²⁺ regulatory model |
Why This Matters
| Feature | E-BLOT Contribution |
|---|---|
| High sensitivity | Detects post-translational modifications like cleaved PARP1, even at low levels |
| Low background | Enables clean separation between target and non-specific bands |
| Imaging consistency | Supports reproducibility across multiple experiments and figures |
| Publication quality | Accepted in a high-impact Nature family journal without imaging post-processing |
“Blots were visualized by Pro e-BLOT Touch Imager according to the manufacturer’s instructions.”
— Jiang et al., Cell Discovery, 2023
Scientific Impact: Enabling a Discovery
Without the high-quality, quantifiable imaging E-BLOT provided, this study’s key conclusions around MLKL’s RIPK3-independent function in suppressing parthanatos would have lacked visual molecular confirmation. The clarity of E-BLOT’s Western blot images helped:
Validate stress pathway activation
Confirm protein knockouts and reconstitutions
Trace protein localization across cell fractions
In a world where data credibility is everything, E-BLOT delivered.
Ready to Elevate Your Protein Workflows?
Whether you’re investigating immune checkpoints, stress responses, or signal transduction, the Pro E-BLOT Touch Imager delivers the band sharpness, consistency, and publication-grade quality trusted by top-tier researchers.[Request a Demo or Data Sheet]
Acknowledgments
Portions of this blog post, including figures and excerpts, are reproduced with permission from Jiang et al., "A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma," Cell Research, 2023.
Read the full study: Cell Research Article